Biohaven (BHVN) Cash from Investing Activities (2021 - 2026)

Biohaven (BHVN) has 6 years of Cash from Investing Activities data on file, last reported at $15.2 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 90.77% year-over-year to $15.2 million; the trailing twelve-month figure through Mar 2026 stood at $150.9 million (up 232.22% YoY), and the FY2025 full-year result was $300.6 million, up 222.69% from the prior year.
• Cash from Investing Activities rose to $15.2 million in Q1 2026, from -$13.7 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $165.0 million in Q3 2025 to a low of -$264.0 million in Q4 2022.
• A 5-year average of -$6.1 million and a median of -$3.9 million in 2023 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities sank 131251.24% in 2022 and jumped 3313.5% in 2024, its largest moves.
• Tracing BHVN's Cash from Investing Activities over 5 years: stood at -$264.0 million in 2022, then jumped by 98.52% to -$3.9 million in 2023, then sank by 2140.06% to -$87.7 million in 2024, then surged by 84.33% to -$13.7 million in 2025, then jumped by 210.72% to $15.2 million in 2026.
• Business Quant data shows BHVN's Cash from Investing Activities at $15.2 million in Q1 2026, -$13.7 million in Q4 2025, and $165.0 million in Q3 2025.